Graves’ disease, an autoimmune disorder affecting the thyroid gland, remains frequently misdiagnosed, leaving many women untreated despite enduring symptoms for months or even years. The condition causes the thyroid to produce excessive amounts of the hormone thyroxine, which regulates numerous bodily functions, including heart rate, digestion, and reproductive cycles.

The disease is five to ten times more common in women than men and typically manifests before the age of 50. However, because Graves’ disease is less common than hypothyroidism—an underactive thyroid condition more widely recognized by medical professionals—many cases are overlooked. Patients often report symptoms such as weight loss, rapid heartbeat, anxiety, hot flushes, insomnia, and irregular menstrual cycles, which are frequently mistaken for stress, anxiety, or menopause-related issues.

One of the challenges in diagnosing Graves’ is that some of its most recognizable symptoms—like weight loss and nervousness—can initially be regarded as positive or attributed to other common health concerns. Furthermore, approximately 20% of patients experience eye changes such as bulging or staring eyes, but this sign is absent in the majority, which may delay suspicion of the disease.

The typical diagnostic pathway begins with blood tests measuring thyroid hormone levels, and in some cases, an ultrasound is performed to check for thyroid nodules. Treatment usually involves daily medication such as carbimazole to regulate hormone production. Nonetheless, patients frequently report that their symptoms are dismissed or misattributed to mental health issues or menopausal changes, leading to ineffective treatments including antidepressants or hormone replacement therapy.

Several women have shared personal experiences underscoring the difficulties of obtaining a timely diagnosis. A notable recent case involved actress Daisy Ridley, who disclosed in 2024 that she was diagnosed with Graves’ after months of symptoms including racing heartbeat, weight loss, shaking hands, and exhaustion. Initially, she had attributed these signs to stress.

Healthcare professionals emphasize that for patients experiencing anxiety, insomnia, palpitations, or other related symptoms, especially women in mid-life, thyroid function tests should be considered early to avoid misdiagnosis. In addition, those undergoing evaluation for atrial fibrillation, a heart rhythm disorder that can present with similar symptoms, should have their thyroid thoroughly assessed.

Experts advise individuals who believe they may have Graves’ disease to keep a detailed record of symptoms over several weeks and consult their physician about specific thyroid testing. The goal is to improve awareness among general practitioners and reduce the tendency to attribute symptoms solely to psychological or hormonal causes.

This underdiagnosis of Graves’ disease highlights the need for increased education and vigilance among healthcare providers to ensure appropriate testing and timely intervention. Without proper diagnosis, many patients continue to suffer from symptoms that significantly impact quality of life despite available treatments.